Phase I-II trial of 14 day infusional 6-Mercaptopurine in advanced colorectal cancer

By Lokich J.   Moore C.   Anderson N.   Bern M.   Coco F.   Dow E.   Zipoli T.  

European Journal of Cancer, Vol. 34, Iss. 4, 1998-03 ,pp. : 584-585

Elsevier

Access to resources Recommend Favorite

Autologous Dendritic Cell Based Adoptive Immunotherapy of Patients with Colorectal Cancer—A Phase I-II Study

By Hunyadi János   András Csilla   Szabó Imre   Szántó János   Szluha Kornélia   Sipka Sándor   Kovács Péter   Kiss Attila   Szegedi Gyula   Altorjay István   Sápy Péter   Antal-Szalmás Péter   Tóth László   Fazekas György   Rajnavölgyi Éva  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 357-365

Springer Publishing Company

Access to resources Recommend Favorite

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer - a randomised phase II-III trial of the EORTC Gastrointestinal Group

By Wils J.   Blijham G.H.   Wagener T.   De Greve J.   Jansen R.L.H.   Kok T.C.   Nortier J.W.R.   Bleiberg H.   Couvreur M.L.   Genicot B.   Baron B.   on behalf of the EORTC Gastrointestinal Group  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 346-352

Elsevier

Access to resources Recommend Favorite

Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer

By Alonso V.   Escudero P.   Zorrilla M.   Isla M.D.   Herrero A.   Mayordomo J.I.   Martinez-Trufero J.   Saenz A.   Tres A.   Anton A.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2385-2391

Elsevier

Access to resources Recommend Favorite

Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer

By            

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 951-959

Spandidos Publications

Access to resources Recommend Favorite